In 2017, EQT reportedly paid a high price for pan-European dental group Curaeos. Two years on, and the group is underperforming. We speak to an operator familiar with the business to find out more.
From psychiatric provider Priory Group, to nursing home group Four Seasons and PE-backed homecare company City & County Healthcare, HBI hears UK deals are off the cards until political certainty can be restored. We speak to advisers and enquire on the status of deals that could go ahead in the new year.
There was speculation over the summer that the UK's biggest dental player by revenue, Mydentist (rebranded from IDH) was set to sell - and then all went quiet, drowned out in part by noise about Brexit and a possible election. But a sale is definitely on the cards next year and HBI hears rumours that investor Carlyle has been tentatively seeking earlier suitors for an accelerated exclusive bilateral deal before Christmas - though sources close to the company dismiss this suggestion out of hand.
Healthcare private equity group Archimed has sold its fast-growing Italian dental chain Primo Group to Milan-based investor Askia for an undisclosed sum. The acquisition is the latter's first healthcare service investment.
Nearly a third of all private equity-owned health care businesses in Europe have been held for at least five years, according to the new HBI Deals Pipeline tool. That suggests many private equity houses are struggling to sell on their investments.
Germany spends more on healthcare in real terms than any country in Europe. Alongside France, it also has the highest spending ratio for healthcare at 11.2% GDP. Here, we show you how the German for-profit healthcare market breaks down by sector and give you some insight into M&A in its three biggest markets.
What is integrated health care as practiced today in Europe? What can it deliver? And what are the barriers to its adoption>? We look at the lessons from three large projects that have all run for over a decade - The Wigan Deal (UK), Tiohundra (Sweden) and Kinzigtal/OptiMedis (Germany). All three will present at the HBI Policy Summit, April 20-22, 2020, London.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
